MENS: Jyong Biotech Corp Average Forecast Price

Corporate company logo of Jyong Biotech Limited (MENS)

The price action of Jyong Biotech Ltd (MENS) relies on stable raw material logistics that eliminate supply disruptions, with the metric reaching 0.00. Jyong Biotech Ltd develops plant-based medicines through Asian alliances and acquires distribution networks. However, business success is constrained by strict regulatory oversight and the potential for failure during new product launches, which could dampen financial performance.

MENS (Jyong Biotech) Price Target Chart history from 06/18/2025 to 11/12/2026
Flagship merchandise of Jyong Bio

The potential of Jyong Biotech Ltd (MENS) depends on successfully navigating regulatory hurdles when bringing plant-based pharmaceuticals to market. The consensus forecast aggregates average fair value estimates of the stock from leading investment houses, reflecting the collective expectations of analysts. This metric allows for a comparison between the current price and the asset's fundamental value. Investors utilize this indicator to determine the long-term capitalization trend. By analyzing the dynamics of the market's target consensus, one can assess the permissible risks of margin lending.

Competitors of Jyong Biotech Ltd

Consensus Target haleon.com HLN|Analyst Consensus Forecast KVUE (Kenvue)|Verona Pharma PLC (VRNA) - Average Forecast Price|LGND - Price Target Chart|AMRX (Amneal Corp) - Broker Consensus Forecast|Perrigo Company plc (PRGO) - Price Target Chart|ALVO - Analyst Median Target|Price Target Chart Liquidia|Galapagos N.V. - Forecast Levels Chart|Analyst Consensus Forecast ANIP|MNKD (Afrezza) - Fair Value Consensus|Analyst Consensus Forecast AMPH (Amphastar Pharmaceuticals)|Analyst Consensus Forecast pacira.com PCRX|SPRY - Price Target Chart|Fair Value Consensus TBPH (Theravance Biopharma Inc)|Aquestive Pharma (AQST) - Price Target Chart|Consensus Target scPharmaceuticals|TECX (Tectonic Therapeutic Inc.) - Analyst Consensus Forecast|Analyst Consensus Forecast tonixpharma.com|Consensus Target SXTC (China SXT Pharmaceuticals)|EPRX (eupraxiapharma.com) - Fair Value Consensus|Price Target Chart BioHarvest BHST|Invizyne (EXOZ) - Average Forecast Price|ORMP: Consensus Target|Entera Bio Ltd. - Analyst Forecast Prices|HYFT: Analyst Consensus Forecast|ABVC BioPharma Inc. - Fair Value Consensus|CPIX (Cumberland Pharma) - Analyst Consensus Forecast|Average Forecast Price Quantum BioPharma Corp QNTM|Price Target Chart FibroGen, Inc. (FGEN)|TELO (telomirpharma.com) - Fair Value Consensus|Price Target Chart Rani Therapeutics Holdings, Inc. RANI|Analyst Forecast Prices SNYR (Synergy CHC Corp.)|RLYB: Consensus Target|Average Forecast Price Lexaria Bioscience|Pulmatrix, Inc. (PULM) - Price Target Chart|Average Forecast Price Pheton Holdings (PTHL)|Price Target Chart Aptorum Group Ltd|Broker Consensus Forecast LYRA (Lyra Therapeutics Inc.)|Analyst Consensus Forecast IBO|tnfpharma.com (TNFA) - Analyst Target Range|cbdMD - Consensus Target|Fair Value Consensus PRFX|Auris Medical - Analyst Consensus Forecast|LIPO: Price Target Chart|OPTN: Analyst Consensus Forecast|PIRS - Analyst Median Target|Price Target Chart Procaps Group S.A.|Average Forecast Price petrospharma.com PTPI|Consensus Target QLI (Qilian International Holding)|Analyst Forecast Prices SLRN|Analyst Consensus Forecast TFFP (TFF Pharma)